GPCR

finance numbers tape money
Biotech

Novo Nordisk inks $812M Deep Apple deal to pursue obesity target

The Danish drugmaker has partnered with Deep Apple Therapeutics to access small molecules against a non-incretin GPCR target.
Nick Paul Taylor Jun 11, 2025 7:00am
graphic image of different colored hands shaking

Sotio takes up option on ADCs, Boehringer inks discovery pact

Mar 13, 2025 10:53am
Three blocks displaying from left to right a person a handshake and another person

Exicure buys GPCR's US unit and clinical-stage blood cancer drug

Jan 23, 2025 5:01am
IPO initial public offering

Septerna goes public with upsized offering of $288M

Oct 25, 2024 10:29am
IPO

GPCR firm Septerna files for IPO on strength of preclinical data

Oct 3, 2024 6:00am
Light speed travel time warp traveling in outer space galaxy

Lilly-backed Superluminal speeds toward the clinic with $120M

Sep 9, 2024 7:00am